Pharmaceutical Technology

DECEMBER 5, 2022

Collectively, cannabinoid receptors (CB1 and CB2) are currently the most popular targets in preclinical stage of development, with 391 drugs tagged in total. In most EU and Commonwealth countries, including the UK, New Zealand and Australia, cannabinoids are legal for medical use.

Controlled Substances 98

Controlled Substances Compounding Immunization 98

pharmaphorum

APRIL 5, 2022

Immunocore now has approval on both side of the Atlantic for Kimmtrak – the first cancer therapeutic based on T cell receptor (TCR) technology – after getting a green light from the European Commission. Uveal melanoma is a rare cancer of the eye, which in the majority of patients is localised. ” Image by Pexels from Pixabay

Labelling 52

Labelling Chemotherapy Immunization 52

pharmaphorum

DECEMBER 23, 2022

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. These are particularly important in the progression of certain blood cancers.

Immunization 52

Immunization Hospitals Vaccines 52

PharmaShots

MARCH 9, 2023

Education: She is a Post Graduate Research Fellow in Gastroenterology and Immunology from Stanford University School of Medicine. Designation: Chief Scientific Officer Previous company: Toumaz UK Ltd. (15 Other Affiliations: Alison works as a visiting researcher at Imperial College's Institute of Biomedical Engineering.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

European Pharmaceutical Review

NOVEMBER 10, 2022

Advanced light microscopy techniques have emerged as a foundation of biomedical research, capable of visualising cellular functions at very high resolution whilst being minimally invasive to the cells or tissues of interest. This will help researchers to understand how formulation can improve cellular uptake to be more efficient.

Labelling 96

Labelling Compounding 96

Pharmaceutical Technology

MARCH 17, 2023

Over the last twenty years, there has been a major rise in risk sharing agreements in the pharmaceutical space, said Alex Watt, GlobalData’s principal research analyst, at a recent webinar on the same topic. In some cases, she said, “[drug] innovation would have been otherwise hindered by their price tag alone”.

Pharmaceutical Companies 102

Pharmaceutical Companies Pharmaceutical Companies Communication 102